申请人:NIKEM RESEARCH S.R.L.
公开号:EP1873150A1
公开(公告)日:2008-01-02
New ligands for the ORL-1 receptor are described, useful for antagonising the activity of said receptors in a patient in need thereof, and for preventing and treating illnesses dependent on the activation of this receptor. The new compounds conform to structural formula (I)
In formula (I) inter alia, at least one of the two R4 substituents is a fluorine atom and at least one among R2 and R3 is a group -(CH2)n-CONRaRb, where R1, R2, R3, R4, n, Ra, Rb are defined in the description.
本文描述了 ORL-1 受体的新配体,可用于拮抗有需要的患者体内上述受体的活性,以及预防和治疗依赖于该受体激活的疾病。这些新化合物符合结构式 (I)
在式 (I) 中,两个 R4 取代基中至少有一个是氟原子,R2 和 R3 中至少有一个是基团-(CH2)n-CONRaRb,其中 R1、R2、R3、R4、n、Ra、Rb 的定义见说明。